Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services, opening its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, invitro diagnosis companies, hospitals and universities with analytical services for blood investigations and hemocompatibility testing.
Q1 Scientific's grand opening ceremony marked the formal inauguration of its new stability storage facility in Villers-le-Bouillet, which spans over 2,000 square meters and is equipped with temperature-controlled storage chambers and monitoring and security systems.